Improving ADCs Therapeutic Index With Bioconjugation & Linker Technologies
Time: 11:45 am
day: Conference Day One
Details:
- Benefits in Utilizing Linkers as Key Elements of ADC Design
- Considerations on Different Linker Technologies and their Applications
- Applying ThioBridge™ Conjugation and Linker Technology to Enhance the Efficacy Brentuximab-MMAE ADCs
